H. Chen-Walden

Galectin antagonist use in mild cases of SARS-CoV-2 cases; pilot feasibility randomised, open label, controlled trial

Madhavi, A. Sigamani, D. Platt, 2020, medRxiv.

Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults.

H. Wendt, B. Sherman, M. Weinberger, 1982, The Journal of allergy and clinical immunology.

Galectin approach to lower covid transmission - Drug Development for clinical use

K. Mayo, H. Chen-Walden, D. Platt, 2022, medRxiv.

An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial

K. Mayo, Michelle C Miller, H. Chen-Walden, 2023, Vaccines.

Carbohydrate prolectin-M, a galectin-3 antagonist, blocks SARS-CoV-2 activity

K. Mayo, Michelle C Miller, D. Platt, 2022, International journal of health sciences.